Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

RX-207, a Small Molecule Inhibitor of Protein Interaction with Glycosaminoglycans (SMIGs), Reduces Experimentally Induced Inflammation and Increases Survival Rate in Cecal Ligation and Puncture (CLP)-Induced Sepsis.

Juhas S, Harris N, Il'kova G, Rehák P, Zsila F, Yurgenzon Kogan F, Lahmy O, Zhuk R, Gregor P, Koppel J.

Inflammation. 2018 Feb;41(1):307-314. doi: 10.1007/s10753-017-0688-0.

PMID:
29110154
2.

[Thoughts about valvular abnormalities yesterday and today].

Gregor P, Línková H.

Vnitr Lek. Summer 2017;63(5):322-327. Review. Czech.

PMID:
28726430
3.

Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.

Sánchez D, Gregor P, Čurila K, Hoffmanová I, Hábová V, Tučková L, Tlaskalová-Hogenová H.

Autoimmunity. 2016 Dec;49(8):554-562. Epub 2016 Sep 30.

PMID:
27689957
4.

Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis.

Harris N, Koppel J, Zsila F, Juhas S, Il'kova G, Kogan FY, Lahmy O, Wildbaum G, Karin N, Zhuk R, Gregor P.

Inflamm Res. 2016 Apr;65(4):285-94. doi: 10.1007/s00011-016-0915-4. Epub 2016 Jan 21.

PMID:
26794621
5.

[Takotsubo cardiomyopathy - what has changed - editorial].

Gregor P.

Vnitr Lek. 2015 Jul-Aug;61(7-8):615-7. Czech. No abstract available.

PMID:
26375685
6.

Variants in miRNA regulating cardiac growth are not a common cause of hypertrophic cardiomyopathy.

Curila K, Benesova L, Tomasov P, Belsanova B, Widimsky P, Minarik M, Zemanek D, Veselka J, Gregor P.

Cardiology. 2015;130(3):137-42. doi: 10.1159/000369247. Epub 2015 Jan 24.

PMID:
25633875
7.

[Mitral stenosis].

Gregor P, Línková H.

Vnitr Lek. 2014 Apr;60(4):304-9. Czech.

PMID:
24985989
8.

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.

Tomašov P, Minárik M, Zemánek D, Čadová P, Homolová S, Čurilka K, Pěnička M, Benešová L, Belšánová B, Gregor P, Veselka J.

Folia Biol (Praha). 2014;60(1):28-34.

9.

Comparison of long-term effect of dual-chamber pacing and alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.

Krejci J, Gregor P, Zemanek D, Vyskocilova K, Curila K, Stepanova R, Novak M, Groch L, Veselka J.

ScientificWorldJournal. 2013 Nov 11;2013:629650. doi: 10.1155/2013/629650. eCollection 2013.

10.

Infekční endokarditida u intravenózních toxikomanů.

Gregor P.

Vnitr Lek. 2013 Oct;59(10):874-5. Czech. No abstract available.

PMID:
24303564
11.

Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.

Harris N, Kogan FY, Il'kova G, Juhas S, Lahmy O, Gregor YI, Koppel J, Zhuk R, Gregor P.

Biochim Biophys Acta. 2014 Jan;1840(1):245-54. doi: 10.1016/j.bbagen.2013.09.023. Epub 2013 Sep 21.

PMID:
24060749
12.

[Malignant heart neoplasms].

Gregor P.

Vnitr Lek. 2013 May;59(5):342-3. Czech. No abstract available.

PMID:
23795367
13.

[Aortic stenosis].

Gregor P, Línková H.

Vnitr Lek. 2013 Apr;59(4):277-83. Review. Czech.

PMID:
23711053
14.

[Cardiac myxoma--editorial].

Gregor P.

Vnitr Lek. 2013 Feb;59(2):94-5. Czech. No abstract available.

PMID:
23599968
15.

[Aortic regurgitation].

Gregor P, Línková H.

Vnitr Lek. 2013 Feb;59(2):99-104. Review. Czech.

PMID:
23461398
16.
17.

Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy.

Curila K, Benesova L, Penicka M, Minarik M, Zemanek D, Veselka J, Widimsky P, Gregor P.

Acta Cardiol. 2012 Feb;67(1):23-9.

PMID:
22455086
18.

From preoperative to intraoperative detection of hyperfunctioning parathyroid glands using tetrofosmin (99mTc) in primary hyperparathyroidism.

Balogova S, Cambal M, Simkova A, Kekenak L, Stecova A, Gregor P, Kinova S, Labas P.

Bratisl Lek Listy. 2011;112(12):695-700.

PMID:
22372335
19.

A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen.

Gregor P, Huang QD, Gallardo HF, Rasalan TS, Morris MJ.

Clin Genitourin Cancer. 2012 Jun;10(2):126-9. doi: 10.1016/j.clgc.2011.12.002. Epub 2012 Jan 27. No abstract available.

20.

Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.

Pasinetti GM, Wang J, Marambaud P, Ferruzzi M, Gregor P, Knable LA, Ho L.

Exp Neurol. 2011 Nov;232(1):1-6. doi: 10.1016/j.expneurol.2011.08.014. Epub 2011 Aug 30.

21.

Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice.

Orlandi F, Guevara-Patiño JA, Merghoub T, Wolchok JD, Houghton AN, Gregor PD.

Vaccine. 2011 May 9;29(20):3646-54. doi: 10.1016/j.vaccine.2011.03.017. Epub 2011 Mar 22.

PMID:
21435405
22.

[The incidence of infective endocarditis and issues associated with its diagnosis].

Gregor P.

Vnitr Lek. 2011 Feb;57(2):130-1. Czech. No abstract available.

PMID:
21416848
23.

Reducing prescribing errors: can a well-designed electronic system help?

Went K, Antoniewicz P, Corner DA, Dailly S, Gregor P, Joss J, McIntyre FB, McLeod S, Ricketts IW, Shearer AJ.

J Eval Clin Pract. 2010 Jun;16(3):556-9. doi: 10.1111/j.1365-2753.2009.01159.x. Epub 2010 Jan 21.

PMID:
20102435
24.

Establishment of a protein frequency library and its application in the reliable identification of specific protein interaction partners.

Boulon S, Ahmad Y, Trinkle-Mulcahy L, Verheggen C, Cobley A, Gregor P, Bertrand E, Whitehorn M, Lamond AI.

Mol Cell Proteomics. 2010 May;9(5):861-79. doi: 10.1074/mcp.M900517-MCP200. Epub 2009 Dec 20.

25.

Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

Curila K, Benesova L, Penicka M, Minarik M, Zemanek D, Veselka J, Widimsky P, Gregor P.

Genet Test Mol Biomarkers. 2009 Oct;13(5):647-50. doi: 10.1089/gtmb.2009.0041.

PMID:
19645627
26.

Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.

Maruskova M, Gregor P, Bartunek J, Tintera J, Penicka M.

J Thorac Cardiovasc Surg. 2009 Jul;138(1):62-8. doi: 10.1016/j.jtcvs.2008.11.040. Epub 2009 Feb 7.

27.

The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

Penicka M, Gregor P, Kerekes R, Marek D, Curila K, Krupicka J; Candesartan use in Hypertrophic And Non-obstructive Cardiomyopathy Estate (CHANCE) Study Investigators.

J Mol Diagn. 2009 Jan;11(1):35-41. doi: 10.2353/jmoldx.2009.080082. Epub 2008 Dec 12.

28.

[Cardiac amyloidosis].

Gregor P.

Vnitr Lek. 2008 Oct;54(10):948-9. Czech. No abstract available.

PMID:
19009759
29.

NOPdb: Nucleolar Proteome Database--2008 update.

Ahmad Y, Boisvert FM, Gregor P, Cobley A, Lamond AI.

Nucleic Acids Res. 2009 Jan;37(Database issue):D181-4. doi: 10.1093/nar/gkn804. Epub 2008 Nov 4.

30.

[Acute pericarditis as an organic manifestation of the acute infection Chlamydia pneumoniae].

Rýzlová M, Gregor P.

Vnitr Lek. 2008 Sep;54(9):866-70. Czech.

PMID:
18924348
31.

Promoting older adults' well-being through Internet training and use. Response to Shapira et al.

Dickinson A, Gregor P.

Aging Ment Health. 2008 May;12(3):410. doi: 10.1080/13607860802200128. No abstract available.

PMID:
18728955
32.

Frequency of representative single nucleotide polymorphisms associated with inflammatory bowel disease in the Czech Republic and Slovak Republic.

Hosek J, Bartosová L, Gregor P, Kolorz M, Díte P, Bátovský M, Bartos M.

Folia Biol (Praha). 2008;54(3):88-96.

33.

Expression of prostate-specific membrane antigen in renal cortical tumors.

Al-Ahmadie HA, Olgac S, Gregor PD, Tickoo SK, Fine SW, Kondagunta GV, Scher HI, Morris MJ, Russo P, Motzer RJ, Reuter VE.

Mod Pathol. 2008 Jun;21(6):727-32. doi: 10.1038/modpathol.2008.42. Epub 2008 Mar 14.

34.

Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.

Felicetti P, Mennecozzi M, Barucca A, Montgomery S, Orlandi F, Manova K, Houghton AN, Gregor PD, Concetti A, Venanzi FM.

Cytotherapy. 2007;9(1):23-34. doi: 10.1080/14653240601048369.

PMID:
18236207
35.

[Tachycardia-induced cardiomyopathy].

Andrásová A, Bufka V, Jirmár R, Gregor P.

Cas Lek Cesk. 2007;146(11):878-81. Czech.

PMID:
18069216
36.

Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine.

Orlandi F, Venanzi FM, Concetti A, Yamauchi H, Tiwari S, Norton L, Wolchok JD, Houghton AN, Gregor PD.

Clin Cancer Res. 2007 Oct 15;13(20):6195-203.

37.

Identification of hibernating myocardium with myocardial contrast echocardiography: comparison with late gadolinium-enhanced magnetic resonance.

Tousek P, Penicka M, Tintera J, Linkova H, Gregor P.

Int J Cardiol. 2008 Aug 1;128(1):117-20. Epub 2007 Aug 29.

PMID:
17761311
38.

Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.

Houghton CS, Engelhorn ME, Liu C, Song D, Gregor P, Livingston PO, Orlandi F, Wolchok JD, McCracken J, Houghton AN, Guevara-Patiño JA.

Vaccine. 2007 Jul 20;25(29):5330-42. Epub 2007 Jun 4.

PMID:
17570567
39.

Decision-making about mode of delivery after previous caesarean section: development and piloting of two computer-based decision aids.

Emmett CL, Murphy DJ, Patel RR, Fahey T, Jones C, Ricketts IW, Gregor P, Macleod M, Montgomery AA; DiAMOND Study Group.

Health Expect. 2007 Jun;10(2):161-72.

40.

Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag.

Felicetti P, Mennecozzi M, Barucca A, Montgomery S, Orlandi F, Manova K, Houghton AN, Gregor PD, Concetti A, Venanzi FM.

Cytotherapy. 2007;9(1):23-34. Erratum in: Cytotherapy. 2007;9(2):205.

PMID:
17361485
41.
42.

[Mitral regurgitation: are we able to properly time the surgical procedure?].

Linková H, Peninka M, Gregor P.

Vnitr Lek. 2006 Nov;52(11):1058-65. Review. Czech.

PMID:
17165525
43.

Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.

Ferrone CR, Perales MA, Goldberg SM, Somberg CJ, Hirschhorn-Cymerman D, Gregor PD, Turk MJ, Ramirez-Montagut T, Gold JS, Houghton AN, Wolchok JD.

Clin Cancer Res. 2006 Sep 15;12(18):5511-9.

44.

Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.

Salpeter SR, Gregor P, Ormiston TM, Whitlock R, Raina P, Thabane L, Topol EJ.

Am J Med. 2006 Jul;119(7):552-9.

PMID:
16828623
45.

Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.

Liao JC, Gregor P, Wolchok JD, Orlandi F, Craft D, Leung C, Houghton AN, Bergman PJ.

Cancer Immun. 2006 Apr 21;6:8.

46.

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

Bergman PJ, Camps-Palau MA, McKnight JA, Leibman NF, Craft DM, Leung C, Liao J, Riviere I, Sadelain M, Hohenhaus AE, Gregor P, Houghton AN, Perales MA, Wolchok JD.

Vaccine. 2006 May 22;24(21):4582-5. Epub 2005 Aug 24.

PMID:
16188351
47.

Adoption and perception of electronic clinical communications in Scotland.

Pagliari C, Donnan P, Morrison J, Ricketts I, Gregor P, Sullivan F.

Inform Prim Care. 2005;13(2):97-104.

48.

What is eHealth (4): a scoping exercise to map the field.

Pagliari C, Sloan D, Gregor P, Sullivan F, Detmer D, Kahan JP, Oortwijn W, MacGillivray S.

J Med Internet Res. 2005 Mar 31;7(1):e9. Review.

49.

Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.

Gregor PD, Wolchok JD, Turaga V, Latouche JB, Sadelain M, Bacich D, Heston WD, Houghton AN, Scher HI.

Int J Cancer. 2005 Sep 1;116(3):415-21.

50.

[Myocarditis].

Gregor P.

Vnitr Lek. 2000 Nov;46(11):801-7. Review. Czech.

PMID:
15637897

Supplemental Content

Loading ...
Support Center